Lipocine Inc. (LPCN): Capital Expenditures
$90.1K
Year ended 2024-12-31
+128.1%
3-year compound annual growth
+4.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $90.1K | +584.2% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $13.2K | -90.2% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $133.8K | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $7.6K | n/a | 2023-03-10, From 2021-01-01 |
| No annual figure between 2018-12-31 and 2021-12-31. | |||
| 2018-12-31 | $0 | n/a | 2019-03-06, From 2018-01-01 |
| 2017-12-31 | $0 | -100.0% | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | $59.6K | +107.9% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $28.7K | -51.9% | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | $59.6K | n/m | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $1.2K | -90.2% | 2015-03-11, From 2013-01-01 |
| 2012-12-31 | $12.3K | n/a | 2014-03-31, From 2012-01-01 |